Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.

Abstract

BACKGROUND & AIMS:

Sirtuin (SIRT1) is a nicotinamide adenine dinucleotide-dependent protein deacetylase that regulates hepatic lipid metabolism by modifying histones and transcription factors. Ethanol exposure disrupts SIRT1 activity and contributes to alcoholic liver disease in rodents, but the exact pathogenic mechanism is not clear. We compared mice with liver-specific deletion of Sirt1 (Sirt1LKO) mice with their LOX littermates (controls).

METHODS:

We induced alcoholic liver injury in male Sirt1LKO and control mice, placing them on Lieber-DeCarli ethanol-containing diets for 10 days and then administering a single dose of ethanol (5 g/kg body weight) via gavage. Liver and serum samples were collected. We also measured messenger RNA levels of SIRT1, SFRS10, and lipin-1β and lipin-1α in liver samples from patients with alcoholic hepatitis and individuals without alcoholic hepatitis (controls).

RESULTS:

On the ethanol-containing diet, livers of Sirt1LKO mice accumulated larger amounts of hepatic lipid and expressed higher levels of inflammatory cytokines than control mice; serum of Sirt1LKO mice had increased levels of alanine aminotransferase and aspartate aminotransferase. Hepatic deletion of SIRT1 exacerbated ethanol-mediated defects in lipid metabolism, mainly by altering the function of lipin-1, a transcriptional regulator of lipid metabolism. In cultured mouse AML-12 hepatocytes, transgenic expression of SIRT1 prevented fat accumulation in response to ethanol exposure, largely by reversing the aberrations in lipin-1 signaling induced by ethanol. Liver samples from patients with alcoholic hepatitis had reduced levels of SIRT1 and a higher ratio of Lpin1β/α messenger RNAs than controls.

CONCLUSIONS:

In mice, hepatic deletion of Sirt1 promotes steatosis, inflammation, and fibrosis in response to ethanol challenge. Ethanol-mediated impairment of hepatic SIRT1 signaling via lipin-1 contributes to development of alcoholic steatosis and inflammation. Reagents designed to increase SIRT1 regulation of lipin-1 can be developed to treat patients with alcoholic fatty liver disease.

• Authors: Huquan Yin, Ming Hu, Xiaomei Liang, Joanne M Ajmo, Xiaoling Li, Ramon Bataller, Gemma Odena, Stanley M Stevens Jr, Min You
• Journal: Gastroenterology (Gastroenterology) Vol. 146 Issue 3 Pg. 801-11 (Mar 2014) ISSN: 1528-0012 [Electronic] United States
• PMID: 24262277 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

Chemical References

• Nerve Tissue Proteins
• Nuclear Proteins
• RNA-Binding Proteins
• TRA2B protein, human
• Serine-Arginine Splicing Factors
• Ethanol
• Lpin1 protein, mouse
• Phosphatidate Phosphatase
• Sirt1 protein, mouse
• Sirtuin 1

Topics

• Animals
• Disease Models, Animal
• Endoplasmic Reticulum Stress (physiology)
• Ethanol (adverse effects)
• Fatty Liver, Alcoholic (etiology, metabolism, physiopathology)
• Hepatocytes (metabolism)
• Humans
• Lipid Metabolism (physiology)
• Liver (enzymology, metabolism)
• Male
• Mice
• Mice, Inbred C57BL
• Mice, Knockout
• Nerve Tissue Proteins (metabolism)
• Nuclear Proteins (metabolism)
• Oxidative Stress (physiology)
• Phosphatidate Phosphatase (metabolism)
• RNA-Binding Proteins (metabolism)
• Serine-Arginine Splicing Factors
• Signal Transduction (physiology)
• Sirtuin 1 (deficiency, genetics, metabolism)